Smartleaf Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4M Buy
13,989
+413
+3% +$419K 0.45% 42
2025
Q4
$14.7M Buy
13,576
+2,109
+18% +$2.02M 0.56% 31
2025
Q3
$8.33M Buy
11,467
+2,820
+33% +$2.1M 0.52% 35
2025
Q2
$6.71M Sell
8,647
-763
-8% -$593K 0.59% 33
2025
Q1
$7.74M Buy
9,410
+514
+6% +$428K 0.75% 19
2024
Q4
$6.88M Buy
8,896
+1,230
+16% +$1.02M 0.7% 22
2024
Q3
$6.73M Buy
7,666
+2,068
+37% +$1.86M 0.82% 16
2024
Q2
$5.09M Buy
5,598
+948
+20% +$758K 0.83% 20
2024
Q1
$3.62M Buy
4,650
+1,144
+33% +$814K 0.7% 28
2023
Q4
$2.01M Buy
+3,506
New +$2.05M 0.54% 43

Other funds holding LLY

Smartleaf Asset Management's LLY Position: Q1 2026 in Review

Smartleaf Asset Management increased its Eli Lilly (LLY) stake by 3% in Q1 2026, buying an estimated $419K and bringing the position to 13,989 shares worth $12.4M. The position accounts for 0.45% of the portfolio, ranked #42.

Smartleaf Asset Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.7M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Smartleaf Asset Management held 13,989 shares of Eli Lilly worth $12.4M as of Q1 2026.
  • Smartleaf Asset Management bought 413 Eli Lilly shares in Q1 2026, an estimated $419K.
  • Eli Lilly made up 0.45% of Smartleaf Asset Management's portfolio in Q1 2026, its #42 holding.
  • Smartleaf Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Smartleaf Asset Management's Eli Lilly position peaked at $14.7M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.